RESUMO
Diabetic nephropathy is associated with lipid deposits in the kidney. We hypothesized that a diet containing polyunsaturated fatty acids (PUFAs) could ameliorate pathogenesis of diabetic kidney diseases associated with lipid depositions in the kidneys. We examined if the pathogenesis and progression of diabetic nephropathy are affected by the type of dietary fat using streptozotocin (45 mg/kg body weight, intravenous)-induced diabetic rats (5-week-old male Sprague-Dawley rats). Streptozotocin-induced diabetic rats were fed a lard diet containing saturated fatty acids or a rapeseed oil diet containing PUFAs (DML and DMR, respectively) for 11 days. Similarly, streptozotocin-nontreated rats were fed a lard diet or a rapeseed oil diet (NL and NR, respectively) for 11 days. Hyperglycemia was induced in DML and DMR, compared with NL and NR groups. The levels of plasma ketone, total cholesterol, and triglyceride (TG) were significantly increased in the DML group. Moreover, albuminuria and renal TG content were enhanced in the DML group. The renal TG content correlated positively with urinary albumin excretion (P < .001). Oil-Red O staining of kidney sections indicated a marked accumulation of neutral lipids in both glomerular and tubular cells in the DML group. In addition, a renal sterol regulatory element-binding protein-1 mature protein increment was induced in the DML group. Conversely, sterol regulatory element-binding protein-1 expression in the kidney was maintained at normal levels in the DMR group. These results suggest that dietary PUFAs may slow the progression of diabetic nephropathy associated with lipid depositions in the kidney.
Assuntos
Diabetes Mellitus Experimental/complicações , Nefropatias Diabéticas/prevenção & controle , Gorduras Insaturadas na Dieta/administração & dosagem , Ácidos Graxos Insaturados/administração & dosagem , Albuminúria , Animais , Compostos Azo , Núcleo Celular/química , Colesterol/sangue , Corantes , Diabetes Mellitus Experimental/sangue , Nefropatias Diabéticas/etiologia , Nefropatias Diabéticas/fisiopatologia , Gorduras na Dieta/administração & dosagem , Ácidos Graxos Monoinsaturados , Cetonas/sangue , Rim/química , Rim/ultraestrutura , Lipídeos/análise , Fígado/química , Masculino , Óleos de Plantas/administração & dosagem , RNA Mensageiro/análise , Distribuição Aleatória , Óleo de Brassica napus , Ratos , Ratos Sprague-Dawley , Proteína de Ligação a Elemento Regulador de Esterol 1/análise , Proteína de Ligação a Elemento Regulador de Esterol 1/genética , Triglicerídeos/análise , Triglicerídeos/sangueRESUMO
In order to determine pyroglutamic acid levels in plasma, we developed a method based on precolumn derivatization of the carboxyl group of pyroglutamic acid with 2-nitrophenylhydrazine. Eight-week-old male SD strain rats were administered 200 mg of an acidic peptide fraction obtained from a commercial wheat gluten hydrolysate containing 0.63 mmol/g pyroglutamyl peptide. After administration, significant amounts of free pyroglutamic acid were observed in the ethanol-soluble fraction of the plasma from the portal vein. In addition, pyroglutamate aminopeptidase digestion of the ethanol-soluble fraction liberated significant amounts of pyroglutamic acid, which indicated the presence of the pyroglutamyl peptide. The presence of the pyroglutamyl peptide in the plasma was further confirmed by size exclusion chromatography. The levels of free and peptide forms of pyroglutamic acid increased significantly and reached a maximum (approximately 40 nmol/mL) at 15 and 30 min after administration, respectively.
Assuntos
Glutens/administração & dosagem , Glutens/química , Peptídeos/administração & dosagem , Ácido Pirrolidonocarboxílico/administração & dosagem , Ácido Pirrolidonocarboxílico/sangue , Triticum/química , Animais , Cromatografia em Gel , Hidrólise , Masculino , Peptídeos/química , Peptídeos/metabolismo , Veia Porta , Piroglutamil-Peptidase I/metabolismo , Ácido Pirrolidonocarboxílico/química , RatosRESUMO
Calcium-bound phosphoryl oligosaccharides (POs-Ca) were prepared from potato starch. Their solubility and in situ absorbability as a calcium source were investigated by comparing with the soluble calcium compounds, calcium chloride and calcium lactate, or insoluble calcium compounds, calcium carbonate and dibasic calcium phosphate. The solubility of POs-Ca was as high as that of calcium chloride and about 3-fold higher than that of calcium lactate. An in situ experiment showed that the intestinal calcium absorption rate of POs-Ca was almost comparable with that of the soluble calcium compounds, and was significantly higher (p<0.05) than that of the insoluble calcium groups. Moreover, the total absorption rate of a 1:1 mixture of the calcium from POs-Ca and a whey mineral complex (WMC) was significantly higher (p<0.05) than that of WMC alone. These results suggest that POs-Ca would be a useful soluble calcium source with relatively high absorption in the intestinal tract.
Assuntos
Cálcio/farmacocinética , Jejuno/metabolismo , Oligossacarídeos/farmacocinética , Animais , Cálcio/química , Cálcio/metabolismo , Cloreto de Cálcio/química , Cloreto de Cálcio/metabolismo , Cloreto de Cálcio/farmacocinética , Compostos de Cálcio/química , Compostos de Cálcio/metabolismo , Compostos de Cálcio/farmacocinética , Absorção Intestinal , Jejuno/cirurgia , Cinética , Lactatos/química , Lactatos/metabolismo , Lactatos/farmacocinética , Masculino , Oligossacarídeos/química , Oligossacarídeos/metabolismo , Organofosfatos/química , Organofosfatos/metabolismo , Organofosfatos/farmacocinética , Ratos , Ratos Wistar , Solubilidade , Amido/química , Especificidade por SubstratoRESUMO
Epsilon-polylysine (epsilon-PL) has been used as a food additive in Japan for many years. In this study, it inhibited human and porcine pancreatic lipase activity in substrate emulsions containing bile salts and phosphatidylcholine, in the concentration range of 10-1000 mg/L. At the same concentrations, it also destroyed the emulsifying activity, suggesting that lipase inhibitory activity and emulsion breakdown activity were associated. Epsilon-PL inhibited porcine pancreatic lipase activity and destroyed emulsion breakdown activity at 1000 mg/L in the substrate containing bile salts and phosphatidylcholine alone. Epsilon-PL did not inhibit lipase activity or affect emulsifying activity at 1000 mg/L in the substrates containing arabic gum and polyvinyl alcohol. A comparison of lipase inhibitory activity between epsilon-PL and three types of alpha-PL with differing polymerization rates was performed. The lipase inhibitory activity of epsilon-PL was not different from that of alpha-PL (44 lysine residues). Epsilon-PL maintained its inhibitory activity after incubation with trypsin, alpha-chymotrypsin and pepsin, whereas alpha-PL did not. The effect of epsilon-PL on postprandial hypertriacylglyceridemia was investigated in rats. The plasma triacylglycerol concentration in rats intragastrically administered > or =15 mg/kg of both fat emulsion and epsilon-PL was significantly lower at 2 and 3 h after administration than that in rats administered fat emulsion alone (P < 0.05). These results strongly suggest that epsilon-PL is able to suppress dietary fat absorption from the small intestine by inhibiting pancreatic lipase activity.